Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Diseases of the Thyroid

  Free Subscription


Articles published in Eur Thyroid J

Retrieve available abstracts of 82 articles:
HTML format



Single Articles


    October 2024
  1. LEE HJ, Hah YS, Cheon SY, Won SJ, et al
    Decreased sirtuin 4 levels promote cellular proliferation and invasion in papillary thyroid carcinoma.
    Eur Thyroid J. 2024;13:e240079.
    PubMed     Abstract available


  2. LEE HJ, Hah YS, Cheon SY, Won SJ, et al
    Decreased sirtuin 4 levels promote cellular proliferation and invasion in papillary thyroid carcinoma.
    Eur Thyroid J. 2024;13:e240079.
    PubMed     Abstract available


  3. GAMBALE C, Prete A, Romei C, Celi A, et al
    Fluctuating obliterative bronchiolitis in RET-mutant medullary thyroid cancer patient treated with selpercatinib.
    Eur Thyroid J. 2024;13:e240189.
    PubMed     Abstract available


  4. ITO Y, Miyauchi A
    Prognostic factors of papillary and follicular carcinomas based on pre-, intra-, and post-operative findings.
    Eur Thyroid J. 2024;13:e240196.
    PubMed     Abstract available


  5. PARK H, Heo J, Ryu HJ, Kim MJ, et al
    The association between BMI and BRAFV600E mutation may differ by primary tumor size.
    Eur Thyroid J. 2024;13:e230255.
    PubMed     Abstract available


  6. YAMAZAKI H, Sugino K, Katoh R, Matsuzu K, et al
    Management of follicular thyroid carcinoma.
    Eur Thyroid J. 2024;13:e240146.
    PubMed     Abstract available


  7. DAVID K, Van Crombrugge P, Van der Biest AM, D'Hondt F, et al
    Apalutamide-induced severe hypothyroidism: case series and practice recommendations for thyroid management.
    Eur Thyroid J. 2024;13:e240158.
    PubMed     Abstract available


  8. TSYBROVSKYY O, Sobrinho-Simoes M, Tallini G
    'Incidental thyroid cancer' is not synonymous with 'overdiagnosis'.
    Eur Thyroid J. 2024;13:e240283.
    PubMed    


  9. COSME I, Figueiredo A, Pinheiro S, Leite V, et al
    Incidental thyroid cancer and overdiagnosis: response to Drs Tsybrovskyy, Sobrinho-Simoes, and Tallini.
    Eur Thyroid J. 2024;13:e240296.
    PubMed    


  10. IMAI H, Watanabe N, Hirose R, Koshibu M, et al
    Subacute thyroiditis during pregnancy: clinical characteristics of seven cases.
    Eur Thyroid J. 2024;13:e240128.
    PubMed     Abstract available


  11. ZHAO C, Sun Z, Wang S, Zhang J, et al
    IgG4 glycosylation contributes to the pathogenesis of IgG4 Hashimoto's thyroiditis via the complement pathway.
    Eur Thyroid J. 2024;13:e240156.
    PubMed     Abstract available


    August 2024
  12. LAI KKH, Aljufairi FMAA, Sebastian JU, Wei Y, et al
    Epidemiology of thyroid-stimulating immunoglobulin in recent-onset symptomatic thyroid eye disease.
    Eur Thyroid J. 2024;13:e230129.
    PubMed     Abstract available


  13. CHUNG CW, Kim K, Park SK, Ju DL, et al
    Selenium levels and their association with thyroid autoimmunity and severe preeclampsia in pregnancy: Insights from a prospective ideal breast milk cohort study.
    Eur Thyroid J. 2024;13:e240007.
    PubMed     Abstract available


  14. ZHANG Z, Yu J, Rainer E, Hargitai L, et al
    The role of [18F]F-DOPA PET/CT in diagnostic and prognostic assessment of medullary thyroid cancer: a 15-year experience with 109 patients.
    Eur Thyroid J. 2024;13:e240089.
    PubMed     Abstract available


  15. BARAN JA, Bojarsky M, Halada S, Ricarte-Filho JC, et al
    Low-invasive somatic oncogenes and lymph node metastasis in pediatric papillary thyroid cancer: implications for prophylactic central neck dissection.
    Eur Thyroid J. 2024;13:e230265.
    PubMed     Abstract available


  16. LEONCINI A, Camponovo C, Paone G, Gamarra E, et al
    Risk of TIRADS-based inappropriate FNAC in autonomous thyroid nodules is clinically negligible.
    Eur Thyroid J. 2024;13:e240123.
    PubMed     Abstract available


  17. MINALDI E, Cappagli V, Lorusso L, Valerio L, et al
    Hand-foot syndrome in sorafenib and lenvatinib treatment for advanced thyroid cancer.
    Eur Thyroid J. 2024;13:e240009.
    PubMed     Abstract available


  18. PERSANI L, Rodien P, Moran C, Edward Visser W, et al
    2024 European Thyroid Association Guidelines on diagnosis and management of genetic disorders of thyroid hormone transport, metabolism and action.
    Eur Thyroid J. 2024;13:e240125.
    PubMed     Abstract available


  19. HECHT F, Valerio L, Goncalves CFL, Harinquet M, et al
    A post-irradiation-induced replication stress promotes RET proto-oncogene breakage.
    Eur Thyroid J. 2024;13:e240028.
    PubMed     Abstract available


  20. VAN HOUTEN P, Nagarajah J, Walraven JEW, Jaeger M, et al
    Digoxin treatment does not reinduce radioiodine uptake in radioiodine refractory non-medullary thyroid carcinoma.
    Eur Thyroid J. 2024;13:e240153.
    PubMed     Abstract available


  21. ZHANG H, Wu S, Hu S, Fan X, et al
    Prediction models of intravenous glucocorticoids therapy response in thyroid eye disease.
    Eur Thyroid J. 2024;13:e240122.
    PubMed     Abstract available


    June 2024
  22. COLOMBO C, Ceruti D, Succi M, De Leo S, et al
    Impact of systemic treatments for advanced thyroid cancer on the adrenal cortex.
    Eur Thyroid J. 2024;13:e230246.
    PubMed     Abstract available


  23. SYED AR, Gorana A, Nohr E, Yuan XK, et al
    Predictors of radioiodine (RAI)-avidity restoration for NTRK fusion-positive RAI-resistant metastatic thyroid cancers.
    Eur Thyroid J. 2024;13:e230227.
    PubMed     Abstract available


  24. FUGAZZOLA L, Deandrea M, Borgato S, Dell'Acqua M, et al
    Radiofrequency ablation is an effective treatment for Bethesda III thyroid nodules without genetic alterations.
    Eur Thyroid J. 2024;13:e240020.
    PubMed     Abstract available


  25. CIRELLO V, Lugaresi M, Moneta C, Dufour P, et al
    Thyroid cancer and endocrine disruptive chemicals: a case-control study on per-fluoroalkyl substances and other persistent organic pollutants.
    Eur Thyroid J. 2024;13:e230192.
    PubMed     Abstract available


  26. TANG MOLLEHAVE L, Knudsen N, Linneberg A, Bulow Pedersen I, et al
    The Danish investigation on iodine intake and thyroid disease (DanThyr): history and implications.
    Eur Thyroid J. 2024;13:e230230.
    PubMed     Abstract available


  27. CHEN J, Li C, Teng W, Shan Z, et al
    A Chinese survey of clinical practice on the management of thyroid eye disease.
    Eur Thyroid J. 2024;13:e230269.
    PubMed     Abstract available


  28. MAVROMATI M, Caironi V, Saiji E, Vargas MI, et al
    Langerhans cell histiocytosis of the suprasellar region: diagnosis based on thyroid cytology.
    Eur Thyroid J. 2024;13:e240011.
    PubMed     Abstract available


  29. URSEM SR, Boelen A, Bruinstroop E, Elders PJM, et al
    A systematic review of subclinical hyperthyroidism guidelines: a remarkable range of recommendations.
    Eur Thyroid J. 2024;13:e240036.
    PubMed     Abstract available


  30. DEMARTIN S, Constantinescu SM, Poppe KG, Maiter D, et al
    Long-term hypothyroidism in patients started on levothyroxine during pregnancy.
    Eur Thyroid J. 2024;13:e240051.
    PubMed     Abstract available


  31. DE VINCENTIS S, Loiacono S, Zanni E, Sueri R, et al
    Subacute thyroiditis in the SARS-CoV-2 era: a multicentre prospective study.
    Eur Thyroid J. 2024;13:e240083.
    PubMed     Abstract available


    April 2024
  32. BARRETO MCA, Treistman N, Cavalcante LBCP, Bulzico D, et al
    Serum anti-Mullerian hormone is lower in patients with multiple radioiodine dose for treatment of pediatric thyroid cancer.
    Eur Thyroid J. 2024;13:e230252.
    PubMed     Abstract available


  33. PITICCHIO T, Russ G, Radzina M, Frasca F, et al
    Head-to-head comparison of American, European, and Asian TIRADSs in thyroid nodule assessment: systematic review and meta-analysis.
    Eur Thyroid J. 2024;13:e230242.
    PubMed     Abstract available


  34. KOSTOPOULOS G, Effraimidis G
    Epidemiology, prognosis, and challenges in the management of hyperthyroidism-related atrial fibrillation.
    Eur Thyroid J. 2024;13:e230254.
    PubMed     Abstract available


  35. RIIS T, Bonnema SJ, Brix TH, Folkestad L, et al
    Hyperthyroidism and the risk of non-thyroid cancer: a Danish register-based long-term follow-up study.
    Eur Thyroid J. 2024;13:e230181.
    PubMed     Abstract available


  36. MULLER I, Maioli S, Armenti M, Porcaro L, et al
    Alemtuzumab-induced thyroid eye disease successfully treated with a single low dose of rituximab.
    Eur Thyroid J. 2024;13:e230236.
    PubMed     Abstract available


  37. JU SH, Ji YB, Song M, Lim JY, et al
    Feasibility of active surveillance in patients with clinically T1b papillary thyroid carcinoma
    Eur Thyroid J. 2024;13:e230258.
    PubMed     Abstract available


  38. CROCE L, Beneventi F, Ripepi F, De Maggio I, et al
    Relationship between maternal obesity and first-trimester TSH in women with negative anti-TPO antibodies.
    Eur Thyroid J. 2024;13:e230213.
    PubMed     Abstract available


    February 2024
  39. HOU S, Sun Y, Yang Z, Tang M, et al
    The diagnostic value of GICA used for intraoperative lymph node FNA-Tg measurement to evaluate thyroid cancer metastases.
    Eur Thyroid J. 2024;13:e230182.
    PubMed     Abstract available


  40. HOLMBERG M, Malmgren H, Berglund PF, Johansson B, et al
    Psychiatric complications in Graves' disease.
    Eur Thyroid J. 2024;13:e230247.
    PubMed     Abstract available


  41. GIANOUKAKIS AG, Choe JH, Bowles DW, Brose MS, et al
    Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancer.
    Eur Thyroid J. 2024;13:e230039.
    PubMed     Abstract available


  42. ZHANG H, Hu H, Wang Y, Duan X, et al
    Predicting glucocorticoid effectiveness in thyroid eye disease: combined value from serological lipid metabolism and an orbital MRI parameter.
    Eur Thyroid J. 2024;13:e230109.
    PubMed     Abstract available


    December 2023
  43. MAVROMATI M, Saiji E, Demarchi MS, Lenoir V, et al
    Unnecessary thyroid surgery rate for suspicious nodule in the absence of molecular testing.
    Eur Thyroid J. 2023;12:e230114.
    PubMed     Abstract available


  44. CHIANG PL, Luo SD, Chang YH, Chou CK, et al
    Radiofrequency ablation for thyroid Bethesda III nodules: preliminary results.
    Eur Thyroid J. 2023;12:e230105.
    PubMed     Abstract available


  45. GAMBALE C, Prete A, Contartese L, Torregrossa L, et al
    Usefulness of second 131I treatment in biochemical persistent differentiated thyroid cancer patients.
    Eur Thyroid J. 2023;12:e230052.
    PubMed     Abstract available


  46. ESZLINGER M, Stephenson A, Mirhadi S, Patyra K, et al
    Activation of mitogen-activated protein kinase signaling and development of papillary thyroid carcinoma in thyroid-stimulating hormone receptor D633H knockin mice.
    Eur Thyroid J. 2023;12:e230049.
    PubMed     Abstract available


  47. JANSEN HI, van Haeringen M, Bouva MJ, den Elzen WPJ, et al
    Optimizing the Dutch newborn screening for congenital hypothyroidism by incorporating amino acids and acylcarnitines in a machine learning-based model.
    Eur Thyroid J. 2023;12:e230141.
    PubMed     Abstract available


  48. WU L, Vaccarella S, Feng CY, Dal Maso L, et al
    Mortality among papillary thyroid cancer patients by detection route: a hospital-based retrospective cohort study.
    Eur Thyroid J. 2023;12:e230127.
    PubMed     Abstract available


  49. RIIS KR, Larsen CB, Medici BR, Jensen CZ, et al
    Hypothyroid women have persistently higher oxidative stress compared to healthy controls.
    Eur Thyroid J. 2023;12:e230167.
    PubMed     Abstract available


  50. WAN Z, Li Y, Dong X, Kang Y, et al
    Influence of metabolic syndrome and lifestyle factors on thyroid nodules in Chinese adult men: a cross-sectional study.
    Eur Thyroid J. 2023;12:e230168.
    PubMed     Abstract available


  51. CONSTANTINESCU SM, Hospel J, Daumerie C, Alexopoulou O, et al
    Significance of thyroperoxidase and thyroglobulin antibodies in medically treated Graves' disease.
    Eur Thyroid J. 2023;12:e230193.
    PubMed     Abstract available


  52. TSENG HH, Lin YB, Lin KY, Lin CH, et al
    A 20-year study of autoimmune polyendocrine syndrome type II and III in Taiwan.
    Eur Thyroid J. 2023;12:e230162.
    PubMed     Abstract available


  53. ESZLINGER M, Stephenson A, Mirhadi S, Patyra K, et al
    Activation of mitogen-activated protein kinase signaling and development of papillary thyroid carcinoma in thyroid-stimulating hormone receptor D633H knockin mice.
    Eur Thyroid J. 2023;12:e230049.
    PubMed     Abstract available


  54. CHIANG PL, Luo SD, Chang YH, Chou CK, et al
    Radiofrequency ablation for thyroid Bethesda III nodules: preliminary results.
    Eur Thyroid J. 2023;12:e230105.
    PubMed     Abstract available


  55. KYRILLI A, Tacelli N, Russo L, Lebrun L, et al
    Autonomously functioning thyroid nodules present intermediate malignancy risk according to European Thyroid Imaging Reporting and Data System (EU-TIRADS) and yield indeterminate cytology results.
    Eur Thyroid J. 2023;12:e230135.
    PubMed     Abstract available


  56. LEE YJ, Choi YH, Lim YH, Kim BN, et al
    Effects of iodine status on thyroid volume and goiter in children living in an iodine-replete area.
    Eur Thyroid J. 2023;12:e230219.
    PubMed     Abstract available


  57. HUSTED L, Rodgaard-Hansen S, Lundgaard MH, Uldall Torp NM, et al
    Biochemical markers of renal function and maternal hypothyroidism in early pregnancy.
    Eur Thyroid J. 2023;12:e230157.
    PubMed     Abstract available


  58. WON HR, Kim MG, Kim MS, Chang JW, et al
    Clinical factors for choosing active surveillance: an analysis of papillary thyroid microcarcinoma patients with recurrence.
    Eur Thyroid J. 2023;12:e230195.
    PubMed     Abstract available


  59. BAHCECIOGLU AB, Gursoy A, Dizbay Sak S, Ilgan S, et al
    The sonographer's and pathologist's perspective of echogenic microfoci in papillary thyroid carcinoma.
    Eur Thyroid J. 2023;12:e230108.
    PubMed     Abstract available


  60. JIA HY, Chen J, Zhai ZX, Fan WW, et al
    Characterization of thyroid metastasis from clear cell renal cell carcinoma on ultrasonography: a report of three cases and literature review.
    Eur Thyroid J. 2023;12:e230121.
    PubMed     Abstract available


    October 2023
  61. DURANTE C, Hegedus L, Czarniecka A, Paschke R, et al
    2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management.
    Eur Thyroid J. 2023;12:e230067.
    PubMed     Abstract available


  62. PINAR-GUTIERREZ A, Romero-Lluch AR, Duenas-Disotuar S, de Lara-Rodriguez I, et al
    Bone metastases from differentiated thyroid cancer: characteristics and prognostic factors in a multicenter series.
    Eur Thyroid J. 2023;12:e230086.
    PubMed     Abstract available


  63. FU J, Fan Z, He L, Liu Q, et al
    Circadian clock disruption in autoimmune thyroiditis.
    Eur Thyroid J. 2023;12:e230035.
    PubMed     Abstract available


  64. URSEM SR, Boelen A, Hillebrand JJ, den Elzen WPJ, et al
    How low can we (reliably) go? A method comparison of thyroid-stimulating hormone assays with a focus on low concentrations.
    Eur Thyroid J. 2023;12:e230123.
    PubMed     Abstract available


  65. MANSO J, Censi S, Clausi C, Piva I, et al
    Circulating miR-146a predicts glucocorticoid response in thyroid eye disease.
    Eur Thyroid J. 2023;12:e230083.
    PubMed     Abstract available


    August 2023
  66. WU J, Hu X, Seal P, Amin P, et al
    Improvement in neck ultrasound report quality following the implementation of European Thyroid Association guidelines for postoperative cervical ultrasound for thyroid cancer follow-up, a prospective population study.
    Eur Thyroid J. 2023;12:e230110.
    PubMed     Abstract available


  67. HALENKA M, Munteanu H, Obereigneru R, Dohnal R, et al
    Ethanol ablation of thyroid cysts in the young with a focus on efficacy and quality of life.
    Eur Thyroid J. 2023;12:e230085.
    PubMed     Abstract available


  68. SOLDEVILA B, Velasco I, Munoz C, Diaz Y, et al
    Longitudinal trajectories of maternal TSH in healthy pregnant women in Catalonia.
    Eur Thyroid J. 2023;12:e230016.
    PubMed     Abstract available


  69. CAPDEVILA J, Deandreis D, Durante C, Leboulleux S, et al
    Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice.
    Eur Thyroid J. 2023;12:e230068.
    PubMed     Abstract available


  70. CAMPI I, Dell'Acqua M, Stellaria Grassi E, Cristina Vigone M, et al
    Unusual causes of hyperthyrotropinemia and differential diagnosis of primary hypothyroidism: a revised diagnostic flowchart.
    Eur Thyroid J. 2023;12:e230012.
    PubMed     Abstract available


  71. PERROS P, Hegedus L
    Teprotumumab in thyroid eye disease: wonder drug or great divider?
    Eur Thyroid J. 2023;12:e230043.
    PubMed     Abstract available


  72. JU N, Hou L, Song H, Qiu Z, et al
    TSH >/=30 mU/L may not be necessary for successful 131I remnant ablation in patients with differentiated thyroid cancer.
    Eur Thyroid J. 2023;12:e220219.
    PubMed     Abstract available


    July 2023
  73. NILSSON JN, Siikanen J, Condello V, Jatta K, et al
    Iodine avidity in papillary and poorly differentiated thyroid cancer is predicted by immunohistochemical and molecular work-up.
    Eur Thyroid J. 2023;12:e230099.
    PubMed     Abstract available


  74. MO C, Chen H, Zhang Q, Guo Y, et al
    Central hyperthyroidism combined with Graves' disease: case series and review of the literature.
    Eur Thyroid J. 2023;12:e220223.
    PubMed     Abstract available


  75. BENABDELKAMEL H, Jaber MA, Dahabiyeh LA, Masood A, et al
    Metabolomic profile of patients on levothyroxine treatment for hypothyroidism.
    Eur Thyroid J. 2023;12:e230062.
    PubMed     Abstract available


  76. BOELEN A, Zwaveling-Soonawala N, Heijboer AC, van Trotsenburg ASP, et al
    Neonatal screening for primary and central congenital hypothyroidism: is it time to go Dutch?
    Eur Thyroid J. 2023;12:e230041.
    PubMed     Abstract available


  77. DAL MASO L, Pierannunzio D, Francisci S, De Paoli A, et al
    Trends in radioactive iodine treatment after total thyroidectomy in Italy, 2001-2018.
    Eur Thyroid J. 2023;12:e230051.
    PubMed     Abstract available


  78. SOARES MN, Borges-Canha M, Neves C, Neves JS, et al
    The role of Graves' disease in the development of thyroid nodules and thyroid cancer.
    Eur Thyroid J. 2023;12:e230055.
    PubMed     Abstract available


  79. JOHANSSON B, Holmberg M, Skau S, Malmgren H, et al
    The relationship between mental fatigue, depression, and cognition in Graves' disease.
    Eur Thyroid J. 2023;12:e230040.
    PubMed     Abstract available


  80. COLOMBO C, Ceruti D, De Leo S, Bilo G, et al
    Management of hypertension during lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm.
    Eur Thyroid J. 2023;12:e230047.
    PubMed     Abstract available


    June 2023
  81. DIAS D, Damasio I, Marques P, Simoes H, et al
    Metastatic follicular thyroid cancer with a longstanding responsiveness to gemcitabine plus oxaliplatin.
    Eur Thyroid J. 2023;12:e220227.
    PubMed     Abstract available


  82. KARA C, Mammadova J, Abur U, Gumuskaptan C, et al
    Genetic testing can change diagnosis and treatment in children with congenital hypothyroidism.
    Eur Thyroid J. 2023;12:e220212.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diseases of the Thyroid is free of charge.